Abstract

The use of clays as vehicle for drug release has been investigated in the scientific environment. This work aims to review articles and patents that present the use of clays in formulations to carry and release drugs. The Scopus, Scielo and Web of Science data bases were used to search for articles and the European Patent Office, United States Patent and Trademark Office and National Institute of Property databases. According to the exclusion criteria, the only articles used were the ones that had the combination of keywords (clays and drug release). The clays studied were used in their natural, synthetic or modified form. The parameters that influence the release of the drugs also were: effect of PH, effect of clay quantity and kinetic study. In view of the excellent performance against the controlled release of drugs, it is evident that there is growing interest in the scientific-technological field in the use of different clays as inorganic support for adsorption and desorption in pharmaceutical compositions.

Keywords: Clays; Biomaterials; Controlled Release of Drugs

Abbreviations: EPO: European Patent Office; USPTO: United States Patent and Trademark Office INPI: National Institute of Industrial Property; APTES: Amino-Propyl-Tri-Ethoxy-Silane

Introduction

For many years research has focused on the development of new carriers for controlled release of drugs. Among numerous nanoscale substrates used for drug delivery, special attention has recently been given to clays because of their chemical and morphological properties. Clay and clay minerals with their different structures, such as lamellar, fibrous or tubular, are the main choice for the design of biomaterials due to its low cost, important intercalation chemistry and low toxicity, allowing them to be chemically modified to improve compatibility with organic molecules [1–3]. The various fields that encompass the applications of clays are mainly in civil engineering, paper industry, effluent treatment, photocatalysis, tissue engineering, cosmetics, controlled drug release and others. These materials can be used in manipulations for drug encapsulation both for dermatological application and for oral administration, thus being important material to be exploited in various technological processes, specifically in the pharmaceutical industry [2,4-15]. The objective of this works a bibliographical and technological prospection regarding clays and clay minerals, including their characteristics and modifications, with emphasis on their use as biomaterials, controlled release of drugs.

Materials and Methods

The research was done in the period of 2007-2018, using the Scopus, Scielo and Web of Science databases; and patent databases: European Patent Office (EPO), United States Patent and Trademark Office (USPTO) and National Institute of Industrial Property (INPI), Brazil. The search was performed according to the combined keywords: Clay, phyllosilicate, functionalized, organophilic, organomodified, synthesis, organofunctionalization and “drug delivery system”. For the review of articles, we analyzed the journal base with the keywords and combinations “article, title, abstract and keyword”, “all indexes” and “topic”, respectively. Review articles and chapters of books were not included in the survey, in addition to papers published in the year 2019. Due to the diversity of articles found, some exclusion criteria were used to restrict the search in order to limit it to articles used, with natural or synthetic cationic clays in controlled release of drugs.

Results and Discussions

Published Articles

The use of the more generalized expressions such as Clay, “Drug delivery system” and Phyllosilicates, showed a greater amount of publications. However, combinations of the expressions, denote a refinement in there search about the analyzed subject, causing hat a smaller number of publications is displayed Table 1 shows the numbers of publications found in the databases cited above. When analyzing (Table 1) it is verified that the Scopus database is the one with the largest number of published articles, while Scielo presents a limitation of publications, even for the most generic expressions. Of the total of 81 articles, it was noticed that some articles are repeated. Based on the exclusion criteria, a brief classification of the profile of the articles and their different objectives could be carried out, which were divided according to the applications. In this study, there presentation of articles indicates that modified or unmodified clays, and combinations with different drugs have majority function in the survey. According to the study of the annual evolution of publications, the use of clays as biomaterials for controlled drug release has been investigated significantly in the last ten years, being the year 2016 the most representative in this segment. (Table 2) presents the main articles and their peculiarities in the different systems (clay AND drug) used for the purpose of incorporating and releasing the drug in the human organism. Among the evaluated drugs, the classes are: analgesics [4], anticancer [16-18] antibiotics, anti-inflammatories [19,20] antibacterials [20-22] and vitamins [23-25]. The clays, natural or synthetic, that stand out in these studies are: montmorillonite, halloysite, laponite, palygorskite and magnesium phyllosilicates. Among the phyillosilicate classification, montmorillonite is prominent within the biomaterials area, because it presents excellent intercalation properties, adsorption capacity and cation exchange, water dispersibility, high surface area, swelling capacity and optimum rheological behavior, as well as its properties. abundance in nature and low cost [4,18,26-32].

Table 1: Number of articles found in the Scopus, Scielo and Web of Science database.

Table 2: Types of clays and drugs in the analyzed articles.

Halloysite, an aluminosilicate with a tubular structure, compared to other nanoparticles such as carbon nanotubes, is a type of natural inorganic tube, cheap, abundantly available, eco and biocompatible [33], because of this has much application for drug releases [34-36]. Laponite, a synthetic hectorite, has specific properties, such as high purity, excellent cation exchange capacity and mechanical toughness, tensile strengths, good extensibility, high transparency, low cost and easy processing [37]. Palygorskite is the most commonly reported fibrous clay in the literature [38- 40] and presents great potential for retention of pollutants, drilling fluids, adsorption and in the pharmaceutical industry [41,42]. Magnesium phyllosilicates of talc type are compounds that present the possibility of modification of their inorganic structure and the viability of insertion of molecules in their lamellae, during the functionalization of the material [43].

Articles Research

Synthesis, Treatments and Modifications of Clays: Physical or chemical changes in the structure of clays are of great industrial interest, generating new materials with specific properties which allows to extend their applications [44]. In this sense, lamellar or fibrous clays can be modified with various organic compounds, giving rise to hybrid materials commonly known as organoclays [4]. The organofunctionalization is one of the most reported modifications in the literature for the application of clays as nanocomposites [16,45,46]. This research has been highlighted due to the improvement of thermal, mechanical and rheological properties, among others [47].

In the case of montmorillonite, a variety of systems are involved in the release of drug, either in the natural form synthetic [48- 51] or modified [30,46,52-55]. In one of these works synthesized montmorillonite by the hydrothermal method and employed in drug delivery systems [4] made use of acid activation to treat natural montmorillonite [34] used two distinct steps to synthesize a polymer / clay hybrid material; in the first step modification of the natural halloysite was achieved by incorporation of the drug (diphenhydramine hydrochloride) and thereafter the second step was continued by the addition of polymer (polyvinyl alcohol), with the aim of reducing the rate of drug release. In the research by [56,57], halloysite nanotubes were functionalized with 3-aminopropyltriethoxysilane (APTES) from hydroxyl groups by a coupling reaction. Dental adhesives were developed in the work of [33] using natural halloysite nanotubes as an inorganic support for the encapsulation of the drug doxycycline. Hydrogels composed of polymers (chitosan and polyvinyl alcohol) were developed by [52], this paper evaluated the influence of the percentage of laponite in the hydrogels, noting the presence of the clays. [58], developed a dendrimer, in the form of nanodiscs, using laponite in its structure. The clay was silanized and modified with succinic anhydride to yield abundant carboxylic groups on its surface and finally conjugated with dendrimers for further incorporation of the drug under study

The hectorite was applied in the studies of [59] to synthesize different printed molecular polymers, varying the amount of hectorite present. Compound microspheres have been described by [60] this system was based on hybridization of chitosan and palygorskite organo-modified, prepared by emulsion cross-linking technique and applied as drug carriers. Palygorskite was modified with hexadecylbetaine (BS-16) to improve compatibility and affinity with the chitosan matrix, enhancing the encapsulation and migration of the drug.

Parameters that Influence Controlled Release: Many drugs are insoluble in aqueous media and / or biological fluids and therefore their effects are decreased due to the low bioavailability. To improve their solubility, the drug molecules can be incorporated into the interlamellar space of pure or modified clays, generating a biomaterial. This pharmaceutical form enables the uniform release of drugs in the body, maintains the therapeutic level with low oscillation, prevents toxic levels and local and systemic side effects [61]. The interaction between the components of the biomaterial formulation (drug, clay and other constituents) will determine the way and the rate with the drug is released from the matrix. Some parameters directly influence the controlled release process, such as the effect of solubility,effect of PH [62,63], effect of clay quantity drug effect carried and kinetic study [4,45,58].

Effects: PH, Amount of Clay and Kinetic Release Study

Anirudhan and the collaborators [18] analyzed the cumulative release percentage in means 1.4 and 7.4. The results indicated that increasing the PH from 1.4 to 7.4 shows a considerable increase in cumulative release. It was observed that 85.0% of paracetamol was released in 10 h at PH 7.4, while only 64.0% was released at PH 1.4. This suggests that the drug release properties are pHsensitive. In the study by [63] the percentages of release decrease with increasing PH from 4.0 to 6.5, due to a possible change in the release mechanism during the process. According to the authors the mechanism of dissolution is the main responsible for the behavior of release of the drug at PH 4.0, while the ion exchange is responsible at PH to 6.5. [4] evaluated different percentages of clay (0, 2, 10 and 20%). There was a decrease in the rate of drug release with an increase in montmorillonite. Since the mechanism of drug release from hydrogel results from both drug diffusion and swelling of the hydrogel. For the authors [4,20,46] all results suggest that it is possible to prepare nanocomposites in which their properties can be controlled by the clay content present in the nanocomposite. Numerous studies are reported in the literature regarding the kinetic release study profile [18-20,59-61]. In the studies ofthe kinetics of in vitro release of 10-hydroxycamptotcin from the nanocomposites were adjusted to the kinetic model of pseudo-second order. The kinetics of doxycycline drug release investigated by [64], inserted in the nanocomposite composed of chitosan, cloisite and polycaprolactone, the values of k and n were calculated, indicating a change in the release. In the studies of [39], in a microspheres system composed of palygorskite and diclofenac sodium, the drug release process was better adjusted to the Ritger-Peppas model.

Patents Research: The results of the survey carried out in the EPO (European Patent Office), USPTO (United States Patent and Trade Mark Office’s) and INPI (National Institute of Industrial Property) are presented in Table 3. The review was carried out with the pre-defined keywords - defined and mentioned in the study of articles. According to the patent results, only one of these meets the main idea of this prospecting and literature review, according to the limited keywords. The patent (US 20090232887 A1) aims to provide a pharmaceutical composition that effectively assists the control in the release of the active substances, such as tramadol and oxycodone (analgesics). It discloses the use of clays (bentonite) in the synthesis of a pharmaceutical slurry, representing about 1.0- 2.5% by weight of the composition containing both dicarbomer and hydroxypropyl methylcellulose, active in the matrix for controlled release [65-68].

Table 3: Quantity of patents deposited in the EPO, USPTO and INPI databases without time interval.

Conclusion

The data presented in this prospection confirm the growing and current interest of the researchers in obtaining hybrid materials with potential for application in controlled release of drugs, a fact evidenced by the number of publications that use different clays and clay minerals as a vehicle for transportation and release in pharmaceutical systems. The analysis of these publications shows the variety of systems used for release, as well as different syntheses and modifications of the clays to improve their properties, as well as parameters that influence the release process such as time, temperature, dosage, PH, system composition, solubility drug, and others. These parameters are shown as an important tool in elucidating the possible interactions between clay/drug and the biological environment, helping to clarify how the process of release of the materials under study can occur. In view of the expressive scientific results discussed herein, clays can be considered for the formulation of pharmaceutical excipients as drug carriers.

References

• Li W, Sun L, Pan L, Lan Z, Jiang T, et al. (2014) Dendrimer-like assemblies based on organoclays as multi-host system for sustained drug delivery Eur. J Pharm Biopharm 88(3): 706-717.
• Cavalcanti GRS, Fonseca MG, da Silva Filho EC, Jaber M (2019) Thiabendazole/bentonites hybrids as controlled release systems Colloids Surfaces B Biointerfaces 176: 249-255.
• Darrat Y, Naumenko E, Cavallaro G, Lazzara G, Lvov Y, et al. (2018) Tubular Nanocontainers for Drug Delivery, in Materials Nanoarchitectonics pp. 85-108.
• Bounabi L, Mokhnachi N B, Haddadine N, Ouazib F, et al. (2016) Development of poly(2-hydroxyethyl methacrylate)/clay composites as drug delivery systems of paracetamol J Drug Deliv Sci Technol 33: 58-65.
• Dizhur D, Lumantarna R, Biggs DT (2017) In-situ assessment of the physical and mechanical properties of vintage solid clay bricks. Mater Struct Constr 50(1): 63.
• Iskender E (2016) Evaluation of mechanical properties of nano-clay modified asphalt mixtures Meas. J Int Meas Confed 93: 359-371.
• Bée A, Obeid L, Mbolantenaina R, Welschbillig M, Delphine Talbot, et al. (2017) Magnetic chitosan/clay beads: A magsorbent for the removal of cationic dye from water. J Magn Magn Mater 421: 59-64.
• Kiaei M, Samariha A, Farsi M (2016) Effects of Montmorillonite Clay on Mechanical and Morphological Properties of Papers Made with Cationic Starch and Neutral Sulfite Semichemical or Old Corrugated Container Pulps BioResources 11(2): 1-3.
• Varghese LR, Das D, Nilanjana Das (2016) Adsorptive removal of nickel(II) ions from aqueous environments using gum based and clay based polyaniline/chitosan nanobiocomposite beads and microspheres: Equilibrium kinetic thermodynamics and ex-situ studies. Korean J Chem Eng 33(7): 2114-2126.
• Wan M, Li Z, Hong H , Qingfeng Wu (2013) Enrofloxacin uptake and retention on different types of clays J. Asian Earth Sci 77(15): 287-294.
• Nesic AR, Velickovic SJ, Antonovic DG (2012) Characterization of chitosan/montmorillonite membranes as adsorbents for Bezactiv Orange V-3R dye. J Hazard Mater 209: 256-263.
• Aranda P, Kun R, Martín Luengo MA, Letaïef S, Dékány I, et al, (2008) Titania-sepiolite nanocomposites prepared by a surfactant templating colloidal route Chem. Mater 20(1): 84-91.
• Ordikhani F, Dehghani M, Simchi A (2015) Antibiotic-loaded chitosan Laponite films for local drug delivery by titanium implants: cell proliferation and drug release studies. J Mater Sci Mater 26(12): 269.
• Sebastião P J, Monteiro M S S B, Brito L M, Rodrigues E, Chávez F V, et al. (2016) Conventional and Fast Field Cycling Relaxometry Study of the Molecular Dynamics in Polymer Nanocomposites for Use as Drug Delivery Systems. J Nanosci Nanotechnol 16(7): 7539-7545.
• Silva PSC, Torrecilha JK, Gouvea PF de M, Máduar M F, De Oliveira SMB, et al. (2015) Chemical and radiological characterization of Peruíbe Black Mud Appl. Clay Sci (118): 221-230.
• Anirudhan TS, Sandeep S, Divya PL (2012) Synthesis and characterization of maleated cyclodextrin-grafted-silylated montmorillonite for the controlled release and colon specific delivery of tetracycline hydrochloride. RSC Adv 25: 9555-9564.
• Anirudhan TS, Sandeep S (2012) Synthesis characterization cellular uptake and cytotoxicity of a multi-functional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells. J Mater Chem 22: 12888-12899.
• Anirudhan TS, Gopal SS, Sandeep S (2014) Synthesis and characterization of montmorillonite/N-(carboxyacyl) chitosan coated magnetic particle nanocomposites for controlled delivery of paracetamol Appl. Clay Sci 88(89): 151-158.
• Anirudhan TS, Parvathy J (2015) Novel pH sensitive composite hydrogel based on functionalized chitosan/clay for the controlled release of a calcium channel blocker Des. Monomers Polym 18(5): 413-423.
• Campbell KT, Craig D Q M, Mcnally T (2010) Ibuprofen-loaded poly(ecaprolactone) layered silicate nanocomposites prepared by hot melt extrusion. J Mater Sci Mater Med 21(8): 2307-2316.
• Dornelas CB, da Silva AM, Dantas CB, Rodrigues CR, Coutinho SS, et al. (2011) Preparation and evaluation of a new nano pharmaceutical excipients and drug delivery system based in polyvinylpyrrolidone and silicate. J Pharm Pharm Sci 14(1): 17-35.
• Feng SS, Mei L, Anitha P, Gan C W, Zhou W (2009) Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel Biomaterials. 30(19): 3297-3306.
• Golbashy M, Sabahi H, Allahdadi I, Nazokdast H (2016) Synthesis the montmorillonite- pomegranate (Punica granatum L.) peel polyphenols nanostructure as a drug delivery vehicle Biomed. Pharmacol J (9): 385- 392.
• Golubeva OY, Pavlova SV, Yakovlev AV (2015) Adsorption and in vitro release of vitamin B1 by synthetic nanoclays with montmorillonite structure. Applied Clay Science 112-113: 10-16.
• Jain S, Datta M (2016) Montmorillonite-alginate microspheres as a delivery vehicle for oral extended release of Venlafaxine hydrochloride. J Drug Deliv Sci Technol 33: 149-156.
• Kevadiya BD, Joshi GV, Patel HA, Ingole PG, Mody HM, et al. (2010) Montmorillonite-Alginate nanocomposites as a drug delivery system: Intercalation and in vitro release of vitamin B1 and vitamin B6 . J Biomater Appl 25(2): 161-177.
• Saha K, Butola BS, Joshi M (2014) Synthesis and characterization of chlorhexidine acetate drug-montmorillonite intercalates for antibacterial applications. Appl Clay Sci 101: 477-483.
• Sarmila Sahoo, Abhisek Sasmal, Debasish Sahoo, PN (2010) Synthesis and Characterization of Chitosan Polycaprolactone Blended with Organoclay for Control Release of Doxycycline Rawal. Med J 118(6): 3167-3175.
• Datta SM (2013) Clay-polymer nanocomposites as a novel drug carrier: Synthesis, characterization and controlled release study of Propranolol Hydrochloride. Appl Clay Sci 80-81: 85-92.
• Mehrdad Mahkam, Abdolrahim Abbaszad Rafi LMG (2014) Preparation of Novel pH-Sensitive Nanocomposites Based on Ionic-Liquid Modified Montmorillonite for Colon Specific Drug Delivery System. Period Biol 116: 37-43.
• Voicu G, Geanaliu-Nicolae R E, Pîrvan A A, Andronescu E (2016) Synthesis, characterization and bioevaluation of drug-collagen hybrid materials for biomedical applications. Int J Pharm 510(2): 474-484.
• Geanalu Nicolae RE, Pirvan A, Andronescu E, Trusca R (2016) Synthesis and Characterization of Drug-Mineral Clay Hybrid Materials for Biomedical Applications as Drug Delivery Systems-Part I. Revista Romana de Materiale-Romanian. Journal of Materials 46(2): 133-141.
• Feitosa S A, Palasuk J, Kamocki K, Geraldeli S, Gregory RL, et al. (2014) Doxycycline-encapsulated nanotube-modified dentin adhesives. J Dent Res 93(12): 1270-1276.
• Ghebaur A, Garea SA, Iovu H (2012) New polymer-halloysite hybrid materials - Potential controlled drug release system. Int J Pharm 436(1): 568-573.
• Massaro M, Riela S, Lo Meo P, Noto R, Cavallaro G, et al. (2014) Functionalized halloysite multivalent glycocluster as a new drug delivery system. J Mater Chem B 2(44): 7732-7738.
• Zargarian SS, Haddadi Asl V, Hematpour H (2015) Carboxylic acid functionalization of halloysite nanotubes for sustained release of diphenhydramine hydrochloride. J Nanoparticle 17: 218.
• Massaro M, Riela S, Baiamonte C, Blanco JLJ, Giordano C, et al. (2016) Dual drug-loaded halloysite hybrid-based glycocluster for sustained release of hydrophobic molecules. RSC Adv 6(91): 87935-87944.
• Roul J, Mohapatra R., Sahoo SK (2016) Antimicrobial activity of novel chitosan/cloisite 10A nanocomposite: Preparation, optimization, characterization and drug delivery behavior 29(4): 1145-1150.
• Wu J, Ding S, Chen J, Zhou S, Ding H (2014) Preparation and drug release properties of chitosan/organomodified palygorskite microspheres. Int J Biol Macromol 68: 107-112.
• Yang L, Choi SK, Shin HJ, Han HK (2013) 3-Aminopropyl Functionalized Magnesium Phyllosilicate As an Organoclay Based Drug Carrier for Improving the Bioavailability of Flurbiprofen. Int J Nanomedicine 8: 4147-4155.
• Lee YS, Song JG, Lee SH, Han HK (2017) Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and ph independent polymers: Preparation and in vitro/in vivo characterization Drug Deliv 24(1): 1731-1739.
• Mustafa R, Luo Y, Wu Y, Guo R, Shi X (2015) Dendrimer-Functionalized Laponite Nanodisks as a Platform for Anticancer Drug Delivery Nanomaterials 5(4): 1716-1731.
• Zhang W, Fu HL, Li XY, Zhang H, Wang N, et al. (2016) Molecularly imprinted polymer doped with Hectorite for selective recognition of sinomenine hydrochloride J Biomater Sci Polym Ed 27(2): 144-156.
• Cernei ER, Maxim A, Maxim DC, Mavru RB (2016) Textural Properties of Amoxicillin-Anionic Clays Composites for Possible Oral Diseases Uses Rev. Chim 67(7): 1306-1308
• Li Y, Bi HY, Li H, Mao XM, Liang YQ (2017) Synthesis, characterization, and sustained release property of Fe3 O4 @(enrofloxacin-layered double hydroxides) nanocomposite Mater. Sci Eng C 78: 886-891.
• Bekri Abbes I, Srasra E (2016) Solid phase mechanochemical synthesis of polyaniline-montmorillonite nanocomposite using grinded montmorillonite as oxidant Mater Sci Semicond Process 56: 76-82.
• Thatiparti TR, Tammishetti S, Nivasu MV (2010) UV curable polyester polyol acrylate/bentonite nanocomposites: Synthesis, characterization, and drug release. J Biomed Mater Res. - Part B Appl Biomater 92(1): 111- 119.
• Qin L, Wang S, Zhang R, Zhu R, Sun X, (2008) Two different approaches to synthesizing Mg-Al-layered double hydroxides as folic acid carriers. J Phys Chem Solids 69(11): 2779-2784.
• Zhang L, Chen M, Jiang Y, Chen M, Ding Y, et al. (2017) A facile preparation of montmorillonite-supported copper sulfide nanocomposites and their application in the detection of H2 O2 . Sensors Actuators B Chem 239: 28- 35.
• Nurtay M, Tuersun M, Cai Y, Açıkgöz M, Wang H, et al. (2017) Spectroscopic study for a chromium-adsorbed montmorillonite. Spectrochim Acta Part A Mol Biomol Spectrosc 173:114-121.
• Chen G, Hao X, Li B L, Luo HQ, et al. (2016) Anodic stripping voltammetric measurement of trace cadmium at antimony film modified sodium montmorillonite doped carbon paste electrode. Sensors Actuators B Chem 237: 570-574.
• Ul Islam M, Khan T, Khattak WA (2013) Bacterial cellulose-MMTs nanoreinforced composite films: Novel wound dressing material with antibacterial properties. Cellulose 20(2): 589-596.
• Massaro M, Campofelice A, Colletti CG, Lazzara G, Noto R, et al. (2018) Functionalized halloysite nanotubes: Efficient carrier systems for antifungine drugs. Appl Clay Sci 160: 186-892.
• Kuang W, Yang Z, Tang Z, Guo B (2016) Wrapping of polyrhodanine onto tubular clay and its prominent effects on the reinforcement of the clay for rubber Compos. Part A Appl Sci Manuf 84: 344-353.
• Liang J, Tan H, Xiao C, Zhou G, Guo S, et al. (2015) Hydroxyl-riched halloysite clay nanotubes serving as substrate of NiO nanosheets for high-performance supercapacitor. J Power Sources 285: 210-216.
• Ahmed FR, Shoaib MH, Azhar M, SH, Yousuf RI, et al. (2015) In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes Colloids Surfaces B Biointerfaces 135: 50-55.
• Khosravi P, Shirvani M, Bakhtiary S, Shariatmadari H (2016) Energetic and Entropic Features of Cu(II) Sorption Equilibria on Fibrous Clay Minerals Water. Air Soil Pollut 227: 354.
• Oliveira MER, De Miranda Santos L, De Gois Da Silva ML, Da Cunha HN (2015) Preparation and characterization of composite polyaniline/ poly(vinyl alcohol)/palygorskite. J Therm Anal Calorim 119(1): 37-46.
• García Romero, Suárez M (2013) Sepiolite–palygorskite: Textural study and genetic considerations. Appl Clay Sci 86: 129-144.
• Hajjaji M, Alami A, Bouadili A El (2006) Removal of methylene blue from aqueous solution by fibrous clay minerals J Hazard Mater 135(1): 188- 192.
• Queiroga LNF, Soares PK, Fonseca MG, De Oliveira FJVE (2016) Experimental design investigation for vermiculite modification: Intercalation reaction and application for dye removal Appl. Clay Sci 126: 113-121.
• Oliveira MJA, Parra DF, Amato VS, Lugão AB (2013) Hydrogel membranes of PVAl/ clay by gamma radiation Radiat Phys Chem 84: 111-114.
• Miranda MO, De Araújo FP, Osajima JA, Silva Filho EC (2016) Incorporation of Zirconium Oxide on the Surface of Palygorskite Clay for Photodegradation of Industrial Dye Mater Sci Forum 869: 768-772.
• Lyra, Ma M, Soares Sobrinho JL, Brasileiro M Hydrophilic and Mucoadhesive Matrix Systems for Controlled Release of Drugs Lat. Am J Pharmacy 26: 784-793.
• Liu C, Hou W, Li L, Li Y, Liu S (2008) Synthesis and characterization of 5-fluorocytosine intercalated Zn-Al layered double hydroxide J. Solid State Chem 181(9): 1792-1797.
• Hussein M Z, Nasir N M, Yahaya A H (2008) Controlled Release Compound Based on Metanilate-Layered Double Hydroxide Nanohybrid. J Nanosci Nanotechnol 8(11): 5921-1528.
• Pang X, Ma X, Li D, Hou W (2013) Synthesis and characterization of 10-hydroxycamptothecin-sebacate-layered double hydroxide nanocomposites. Solid State Sci 16: 71-75.
• Odidi A (2009) Pharmaceutical composition having reduced abuse potential. US 20090232887.

Abstract

The use of clays as vehicle for drug release has been investigated in the scientific environment. This work aims to review articles and patents that present the use of clays in formulations to carry and release drugs. The Scopus, Scielo and Web of Science data bases were used to search for articles and the European Patent Office, United States Patent and Trademark Office and National Institute of Property databases. According to the exclusion criteria, the only articles used were the ones that had the combination of keywords (clays and drug release). The clays studied were used in their natural, synthetic or modified form. The parameters that influence the release of the drugs also were: effect of PH, effect of clay quantity and kinetic study. In view of the excellent performance against the controlled release of drugs, it is evident that there is growing interest in the scientific-technological field in the use of different clays as inorganic support for adsorption and desorption in pharmaceutical compositions.

Keywords: Clays; Biomaterials; Controlled Release of Drugs

Abbreviations: EPO: European Patent Office; USPTO: United States Patent and Trademark Office INPI: National Institute of Industrial Property; APTES: Amino-Propyl-Tri-Ethoxy-Silane